Posts for Entrada Therapeutics, Inc. ($TRDA)

Showing 1 - 2 of 2 Posts

Entrada Therapeutics, Inc. 8-K Report: Key Shareholder Updates on February 24, 2025

•

8-K

•

2025-02-24

Last updated: over 1 year ago

Entrada Therapeutics, Inc. 8-K Report: Key Shareholder Updates on February 24, 2025

Discover essential insights from Entrada Therapeutics' 8-K filing on significant events affecting shareholders. Stay informed about TRDA stock developments and company actions.

Entrada Therapeutics NASDAQ 8-K Filing Biotechnology Public Company Reporting

Entrada Therapeutics 8-K Report: Key Insights & Filing Date January 15, 2025

•

8-K

•

2025-01-15

Last updated: over 1 year ago

Entrada Therapeutics 8-K Report: Key Insights & Filing Date January 15, 2025

Explore the latest 8-K filing by Entrada Therapeutics, Inc. on January 15, 2025, detailing company info, stock data, and regulatory compliance.

Entrada Therapeutics biotechnology NASDAQ TRDA financial reporting XBRL compliance

Financial Reports and Analysis for Entrada Therapeutics, Inc. | SECsense